EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Effects of Oltipraz on the Glycolipid Metabolism and the Nrf2/HO-1 Pathway in Type 2 Diabetic Mice

Yunfei Luo, Shaohua Sun, Yuying Zhang, Shuang Liu, Haixia Zeng, Jin-E Li, Jiadian Huang, Lixuan Fang, Shiqi Yang, Peng Yu, Jianping Liu

Drug Design, Development and Therapy · 2024-12 · Volume 18 · 5685-5700

DOI: 10.2147/dddt.s485729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024-12. Verfasst von Yunfei Luo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism of the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330031…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Diabetes Mellitus, Type 2, Thiophenes, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Oltipraz has various applications, including for treating cancer, liver fibrosis, and cirrhosis. However, its role in regulating metabolic processes, inflammation, oxidative stress, and insulin resistance in STZ-induced T2DM remains unclear. Hence, a comprehensive understanding of how oltipraz ameliorates diabetes, particularly inflammation and oxidative stress, is imperative.

Methods

The negative control (NC), T2DM model (T2DM), and T2DM models treated with oltipraz (OLTI) and metformin (MET) were constructed. The RNA sequencing (RNA-Seq) was performed on the pancreatic tissues. H&E staining was conducted on the liver and pancreatic tissues. The intraperitoneal glucose tolerance test (IPGTT), blood glucose and lipids, inflammatory factors, and oxidative stress indexes were measured. qPCR and Western blotting examined the nuclear factor erythroid-derived 2-like 2 (Nrf2)/ hemoglobin-1 (HO-1) signaling pathway, cell apoptosis-related genes, and Reg3g levels. Immunofluorescence (IF) analysis of the pancreas was performed to measure insulin secretion.

Results

A total of 256 DEGs were identified in OLTI_vs_T2DM, and they were mainly enriched in circadian rhythm, cAMP, AMPK, insulin, and MAPK signaling pathways. Moreover, Reg3g exhibits reduced expression in T2DM_vs_NC, and elevated expression in OLTI_vs_T2DM, yet remains unchanged in MET_vs_T2DM. OLTI reduced fasting blood glucose and alleviated T2DM-induced weight loss. It improved blood glucose and insulin resistance, decreased blood lipid metabolism, reduced inflammation and oxidative stress through the Nrf2/HO-1 signaling pathway, mitigated pancreatic and liver tissue injury, and enhanced pancreatic β-cell insulin secretion. OLTI exhibited anti-apoptosis effects in T2DM. Moreover, OLTI exhibits superior antioxidant activity than metformin.

Conclusion

In summary, OLTI improves blood glucose and insulin resistance, decreases blood lipid metabolism, reduces inflammation and apoptosis, suppresses oxidative stress through the Nrf2/HO-1 signaling pathway, mitigates pancreatic and liver tissue injury, and enhances pancreatic β-cell insulin secretion, thereby mitigating T2DM symptoms. Moreover, Reg3g could be an important target for OLTI treatment of T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Diabetes Mellitus, Type 2ThiophenesDiabetes Mellitus, ExperimentalThionesGlycolipidsAnimalsMiceMaleHypoglycemic AgentsStreptozocinMice, Inbred C57BLPyrazinesOxidative StressSignal TransductionHeme Oxygenase-1Membrane Proteins

Stichwörter der Autor:innen

Nrf2OltiprazT2DMinflammationoxidation stress

Substanzen

NF-E2-Related Factor 2oltiprazThiophenesThionesNfe2l2 protein, mouseGlycolipidsHypoglycemic AgentsStreptozocinPyrazinesHmox1 protein, mouse

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism of the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330031, People's Republic of China.
  • Department of Metabolism and Endocrinology, XinSteel Center Hospital, Xinyu, Jiangxi, 338000, People's Republic of China.
  • Institute for the Study of Endocrinology and Metabolism in Jiangxi Province, Nanchang, Jiangxi, 330031, People's Republic of China.
  • Branch of National Clinical Research Center for Metabolic Diseases, Nanchang, Jiangxi, 330031, People's Republic of China.

Zitieren

APA

Luo, Y., Sun, S., Zhang, Y., Liu, S., Zeng, H., Li, J. E., Huang, J., Fang, L., Yang, S., Yu, P., & Liu, J. (2024). Effects of Oltipraz on the Glycolipid Metabolism and the Nrf2/HO-1 Pathway in Type 2 Diabetic Mice. Drug Design, Development and Therapy, Volume 18, 5685-5700. https://doi.org/10.2147/dddt.s485729

Vancouver

Luo Y, Sun S, Zhang Y, Liu S, Zeng H, Li JE, et al. Effects of Oltipraz on the Glycolipid Metabolism and the Nrf2/HO-1 Pathway in Type 2 Diabetic Mice. Drug Design, Development and Therapy. 2024;Volume 18:5685-5700. doi:10.2147/dddt.s485729

BibTeX
@article{Luo2024,
  author = {Luo, Yunfei and Sun, Shaohua and Zhang, Yuying and Liu, Shuang and Zeng, Haixia and Li, Jin-E and Huang, Jiadian and Fang, Lixuan and Yang, Shiqi and Yu, Peng and Liu, Jianping},
  title = {Effects of Oltipraz on the Glycolipid Metabolism and the Nrf2/HO-1 Pathway in Type 2 Diabetic Mice},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  volume = {Volume 18},
  pages = {5685--5700},
  doi = {10.2147/dddt.s485729}
}
Kostenlos starten →